SCHEDULE: Laurence Lytton Discloses 8.1% Stake in DNA X, Inc.

Laurence W. Lytton has reported beneficial ownership of 120,357 shares, representing 8.1% of the outstanding common stock of DNA X, Inc. as of April 21, 2026.

Summary

• Laurence W. Lytton filed a Schedule 13G, indicating beneficial ownership of 120,357 shares of DNA X, Inc. common stock.
• This holding represents 8.1% of the company's outstanding common stock as of April 21, 2026.
• Lytton has sole voting and dispositive power over 81,469 shares and shared power over 38,888 shares.
• The filing excludes warrants to purchase 22,222 shares, which are subject to a 4.99% beneficial ownership limitation.
• The filing date is May 15, 2026, and the event date requiring the filing was March 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership without any indication of new strategic moves, financial performance, or management changes.

Positives

• Laurence W. Lytton has a significant beneficial ownership stake of 8.1% in DNA X, Inc.
• The filing clarifies the extent of Lytton's holdings and voting/dispositive powers.

Risks

• The beneficial ownership is subject to a 4.99% limitation on warrants to purchase 22,222 shares, which could impact future control or influence if exercised.
• The filing is an amendment (Amendment No. 7), suggesting previous filings and potential ongoing adjustments to ownership.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of beneficial ownership.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for significant beneficial ownership by passive investors. This filing indicates Laurence W. Lytton's substantial, non-controlling interest in DNA X, Inc., which is typical for institutional or individual investors holding more than 5% of a class of securities.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant shareholder's stake, which can influence market perception and potential future corporate actions.
• Management: Awareness of a substantial beneficial owner is important for strategic planning and investor relations.

Next Steps

• Monitor future filings by Laurence W. Lytton for any changes in beneficial ownership.
• Observe DNA X, Inc.'s corporate actions and strategic developments for potential impact of this significant shareholder.

Key Dates

Keywords

DNA X, Inc., Schedule 13G, Laurence W. Lytton, Beneficial Ownership, Common Stock, SEC Filing, Shareholder, Investment